Tag Archives: FDAcopilot

Biotech Funding Overview: Launch of Jade Bio, Brenig’s Introduction, Confo’s Financial Boost & Beyond

Biotech Funding Overview: Launch of Jade Bio, Brenig’s Introduction, Confo’s Financial Boost & Beyond

The development of drugs for autoimmune diseases is challenged by immune responses against biologic therapies. Emerging companies employ innovative techniques, including artificial intelligence and novel biologic drug platforms, to mitigate these risks and develop new treatments. Key advancements and investments in the field of Immunology and Inflammation show the dynamic landscape of biotech: Abiologics launched […]

Continue Reading

Digital Health Brief: Launch of HHS’ AI Office, FDA’s AI Utilization in Surveillance Analysis, and Upcoming Policies | Exclusive Article from FDA Today

Digital Health Brief: Launch of HHS’ AI Office, FDA’s AI Utilization in Surveillance Analysis, and Upcoming Policies | Exclusive Article from FDA Today

The content provided is a brief announcement regarding significant organizational and policy changes in U.S. health technology management, specifically within the Department of Health and Human Services (HHS). The news announced includes the creation of a new Assistant Secretary for Technology Policy position within the HHS, showcasing an elevation of responsibilities previously managed by an […]

Continue Reading

Setting Up Clinical Studies in Compliance with U.S. FDA Regulations

Setting Up Clinical Studies in Compliance with U.S. FDA Regulations

For manufacturers of Class III high-risk medical devices, gathering clinical investigation data is crucial for successful regulatory approval in the United States. The U.S. Food and Drug Administration (FDA) mandates Premarket Approval (PMA) for these products, heavily relying on clinical data to assess device safety and effectiveness. Setting up and conducting a compliant clinical trial […]

Continue Reading

Philips Files Lawsuit Against Independent Lab, Claims Multiple Serious Mistakes in CPAP Foam Testing

Philips Files Lawsuit Against Independent Lab, Claims Multiple Serious Mistakes in CPAP Foam Testing

In a significant legal move, Philips has initiated a lawsuit against PSN Labs, holding them accountable for what it considers critical errors in the risk analysis of soundproofing foam used in its sleep apnea devices. Filed in the U.S. District Court for the Western District of Pennsylvania, Philips contends that the inaccurate conclusions drawn by […]

Continue Reading

FDA Grants Adaptimmune First Approval for an Engineered Cell Therapy Targeting Solid Tumors

FDA Grants Adaptimmune First Approval for an Engineered Cell Therapy Targeting Solid Tumors

Cell therapies, originally developed for treating blood cancers, have marked a significant advancement in cancer treatment. Adaptimmune Therapeutics has notably contributed to this field with the recent FDA approval of its product for synovial sarcoma, a rare cancer that affects soft tissues like muscles and ligaments, primarily in males under 30. This approval of Tecelra […]

Continue Reading

5 Essential Elements to Integrate with Your Design Controls for an Audit-Resistant QMS

5 Essential Elements to Integrate with Your Design Controls for an Audit-Resistant QMS

Design controls are essential quality practices and procedures mandated for medical device companies under 21 CFR Part 820 and ISO 13485:2016. These controls guarantee that medical devices satisfy their intended uses, user needs, and specified requirements. By integrating design controls into the broader Quality Management System (QMS), companies ensure that the risk of future device […]

Continue Reading